277 related articles for article (PubMed ID: 7511693)
1. Microvessel density and distribution in ductal carcinoma in situ of the breast.
Guidi AJ; Fischer L; Harris JR; Schnitt SJ
J Natl Cancer Inst; 1994 Apr; 86(8):614-9. PubMed ID: 7511693
[TBL] [Abstract][Full Text] [Related]
2. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast.
Zolota V; Gerokosta A; Melachrinou M; Kominea A; Aletra C; Scopa CD
Anticancer Res; 1999; 19(4B):3269-74. PubMed ID: 10652623
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.
Rice AJ; Steward MA; Quinn CM
J Clin Pathol; 2002 Dec; 55(12):921-5. PubMed ID: 12461058
[TBL] [Abstract][Full Text] [Related]
4. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.
Guidi AJ; Schnitt SJ; Fischer L; Tognazzi K; Harris JR; Dvorak HF; Brown LF
Cancer; 1997 Nov; 80(10):1945-53. PubMed ID: 9366297
[TBL] [Abstract][Full Text] [Related]
5. Distribution of myofibroblast cells and microvessels around invasive ductal carcinoma of the breast and comparing with the adjacent range of their normal-to-DCIS zones.
Dabiri S; Talebi A; Shahryari J; Meymandi MS; Safizadeh H
Arch Iran Med; 2013 Feb; 16(2):93-9. PubMed ID: 23360631
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast.
Engels K; Fox SB; Whitehouse RM; Gatter KC; Harris AL
J Pathol; 1997 Aug; 182(4):414-20. PubMed ID: 9306962
[TBL] [Abstract][Full Text] [Related]
7. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.
Engels K; Fox SB; Whitehouse RM; Gatter KC; Harris AL
J Pathol; 1997 Feb; 181(2):207-12. PubMed ID: 9120727
[TBL] [Abstract][Full Text] [Related]
8. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
Vartanian RK; Weidner N
Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
[TBL] [Abstract][Full Text] [Related]
9. Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast.
Teo NB; Shoker BS; Jarvis C; Sloane JP; Holcombe C
J Clin Pathol; 2003 Dec; 56(12):919-23. PubMed ID: 14645350
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.
Vogl G; Dietze O; Hauser-Kronberger C
Histopathology; 2005 Dec; 47(6):617-24. PubMed ID: 16324200
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive carcinoma of the breast: angiogenesis and cell proliferation.
Cao Y; Paner GP; Kahn LB; Rajan PB
Arch Pathol Lab Med; 2004 Aug; 128(8):893-6. PubMed ID: 15270612
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and inflammation in ductal carcinoma in situ of the breast.
Lee AH; Happerfield LC; Bobrow LG; Millis RR
J Pathol; 1997 Feb; 181(2):200-6. PubMed ID: 9120726
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of the immunoexpression of Her2÷neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast.
Fota GL; Stepan A; Ciurea RN
Rom J Morphol Embryol; 2012; 53(3 Suppl):805-10. PubMed ID: 23188444
[TBL] [Abstract][Full Text] [Related]
14. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
15. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
Hieken TJ; Farolan M; D'Alessandro S; Velasco JM
Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
[TBL] [Abstract][Full Text] [Related]
16. Biological profile of in situ breast cancer investigated by immunohistochemical technique.
Albonico G; Querzoli P; Ferretti S; Rinaldi R; Nenci I
Cancer Detect Prev; 1998; 22(4):313-8. PubMed ID: 9674874
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.
Şener E; Şipal S; Gündoğdu C
Turk Patoloji Derg; 2016; 32(3):164-70. PubMed ID: 27562390
[TBL] [Abstract][Full Text] [Related]
18. p53 protein expression in ductal carcinoma in situ (DCIS) of the breast.
Rajan PB; Scott DJ; Perry RH; Griffith CD
Breast Cancer Res Treat; 1997 Feb; 42(3):283-90. PubMed ID: 9065612
[TBL] [Abstract][Full Text] [Related]
19. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
20. Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns.
Adler EH; Sunkara JL; Patchefsky AS; Koss LG; Oktay MH
Hum Pathol; 2012 Apr; 43(4):550-6. PubMed ID: 21925705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
